In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic ...

Johnson & Johnson (NYSE:JNJ) today shared new clinical findings from a novel U.S. pilot study of its Abiomed unit’s Impella 5.5 system.

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Medical researchers around the world continue to discover new ways Apple Watch can help save your life. A new study from researchers at the Mayo Clinic offers a deeper look at the Apple Watch’s ECG ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...

Following an acute heart attack, pathological remodeling processes occur in the heart. One consequence is so-called left ...

Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...